Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Review ArticleSpecial Section on Non-Coding RNA: From Biomarker to Therapeutic Tool—Minireview

The Role of Non-Coding RNAs in Chromosomal Instability in Cancer

Swati Mohapatra, Melanie Winkle, Anh N. Ton, Dien Nguyen and George A. Calin
Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 10-19; DOI: https://doi.org/10.1124/jpet.122.001357
Swati Mohapatra
Department of Translational Molecular Pathology (S.M., M.W., A.N.T., G.A.C.), UT Health Graduate School of Biomedical Sciences (S.M.), Program in Molecular Genetic Technology, School of Health Professions (A.N.T.), and Center for RNA Interference and Non-Coding RNAs (G.A.C.), The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts (D.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melanie Winkle
Department of Translational Molecular Pathology (S.M., M.W., A.N.T., G.A.C.), UT Health Graduate School of Biomedical Sciences (S.M.), Program in Molecular Genetic Technology, School of Health Professions (A.N.T.), and Center for RNA Interference and Non-Coding RNAs (G.A.C.), The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts (D.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anh N. Ton
Department of Translational Molecular Pathology (S.M., M.W., A.N.T., G.A.C.), UT Health Graduate School of Biomedical Sciences (S.M.), Program in Molecular Genetic Technology, School of Health Professions (A.N.T.), and Center for RNA Interference and Non-Coding RNAs (G.A.C.), The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts (D.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dien Nguyen
Department of Translational Molecular Pathology (S.M., M.W., A.N.T., G.A.C.), UT Health Graduate School of Biomedical Sciences (S.M.), Program in Molecular Genetic Technology, School of Health Professions (A.N.T.), and Center for RNA Interference and Non-Coding RNAs (G.A.C.), The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts (D.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George A. Calin
Department of Translational Molecular Pathology (S.M., M.W., A.N.T., G.A.C.), UT Health Graduate School of Biomedical Sciences (S.M.), Program in Molecular Genetic Technology, School of Health Professions (A.N.T.), and Center for RNA Interference and Non-Coding RNAs (G.A.C.), The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts (D.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    MicroRNAs implicated in the generation of CIN. miR-22 directly regulates MDC1 through HR-mediated DNA repair and contributes to CIN. miR-26a, miR-28 and miR-186 regulates genes involved in cell cycle checkpoints and contributes to centrosome defect, aneuploidy, double minute, dicentric, and ring chromosomes rendering CIN.

Tables

  • Figures
    • View popup
    TABLE 1

    lncRNAs causative for CIN

    NameTargetMechanismCorrelation to CINReferences
    TERRATerc
    TERT
    Ku70/80
    TRF1/2
    Telomere
    Transcribed from telomeres; regulate telomere length via inhibition of telomerase (Terc, TERT), exonuclease degradation of chromosome ends (Ku70/80-exonuclease 1), formation of telomeric heterochromatin (TRF2-ORC1) and protection of chromosome ends from DNA damage (DNA:RNA hybrids)Negative/positiveSchoeftner and Blasco (2008), Deng et al. (2009), Redon et al. (2010), Aguilera and García-Muse (2012), Pfeiffer and Lingner (2012), Sagie et al. (2017), Mei et al. (2021)
    cenRNACENP-A
    HJURP
    CENP-C
    INCENP
    Aurora B
    Transcribed from centrosomal DNA; Assists kinetochore assembly via interaction with various centromere-associated proteins and the chromosome passenger complexPositiveMurata-Hori and Wang (2002), Wong et al. (2007), Portella et al. (2011), Kato et al. (2013), Ideue et al. (2014), Quénet and Dalal (2014), McNulty et al. (2017)
    Enhancer RNAsAIDIn B cells, AID off-targeting to regions other than the immunoglobulin loci has been related to convergent transcription of enhancer RNAs. Convergent transcription leads to formation of R loops, which impose genomic fragility if not resolved by the RNA exosome, leading to translocations between proto-oncogenes and the potent immunoglobulin enhancers.PositiveMeng et al. (2014), Qian et al. (2014), Pefanis et al. (2015)
    PCAT2CENP-A, HIRA, DAXXTranscribed from fragile 8q24 locus; causes local, ectopic recruitment of CENP-A and other centromere-associated proteins resulting in genome fragilityPositiveArunkumar et al. (2022)
    Ginir and GinirasCep112
    Brca1
    Disruption of the Cep112-Brca1 interaction and downregulation of Cep112 and Brca1 causes centromere defects, chromosome missegregation and increased occurrence of DNA double strand breaks.PositivePanda et al. (2018)
    GUARDINmiR-23a
    BRCA1-BARD1
    Maintains TFR2 (shelterin complex component) expression via sponging of miR-23a to prevent telomere dysfunction.
    Acts as an RNA scaffold for BRCA1-BARD1, forming a ribonucleoprotein complex that influences double strand break repair.
    NegativeHu et al. (2018)
    CCAT2BOP1
    AURKB
    Positively regulates BOP1 expression which in turn upregulates phosphorylation and activation of AURKB. Possibly mediates BOP1-AURKB interaction by scaffolding. Increased pAURKB disrupts chromosome-microtubule attachments and chromosome missegregation.PositiveLing et al. (2013), Chen et al. (2020)
    NORADPUMILIO (PUM1/PUM2)
    SAM68
    Mediates phase-separation of PUM1 and PUM2 proteins, which bind to NORAD via PUMILIO response elements and/or via SAM68. This in turn inhibits the repressive effect of PUMILIO proteins on mRNA targets involved in DNA damage repair and mitosis regulation.NegativeLee et al. (2016), Tichon et al. (2018), Elguindy and Mendell (2021)
    • BARD1, BRCA1-associated RING domain 1; DAXX, death domain–associated protein; HIRA, histone cell cycle regulator; HJURP, Holliday junction recognition protein; INCENP, inner centromere protein; ORC1, origin recognition complex subunit 1; PUM1/PUM2, PUMILIO homolog 1/PUMILIO homolog 2; TERT, telomerase reverse transcriptase.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 384 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 384, Issue 1
1 Jan 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Non-Coding RNAs in Chromosomal Instability in Cancer
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleSpecial Section on Non-Coding RNA: From Biomarker to Therapeutic Tool—Minireview

Non-Coding RNAs in Chromosomal Instability in Cancer

Swati Mohapatra, Melanie Winkle, Anh N. Ton, Dien Nguyen and George A. Calin
Journal of Pharmacology and Experimental Therapeutics January 1, 2023, 384 (1) 10-19; DOI: https://doi.org/10.1124/jpet.122.001357

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Review ArticleSpecial Section on Non-Coding RNA: From Biomarker to Therapeutic Tool—Minireview

Non-Coding RNAs in Chromosomal Instability in Cancer

Swati Mohapatra, Melanie Winkle, Anh N. Ton, Dien Nguyen and George A. Calin
Journal of Pharmacology and Experimental Therapeutics January 1, 2023, 384 (1) 10-19; DOI: https://doi.org/10.1124/jpet.122.001357
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • The Role of CIN in Cancer
    • MicroRNAs Implicated in CIN
    • Long ncRNAs Implicated in CIN
    • Conclusions and Future Perspectives
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics